Long term follow-up of women treated for screen detected atypical ductal hyperplasia or lobular neoplasia in a large UK screening centre
In women with ADH/LN most BCs occur beyond 5 years. ES regimens should therefore extend to at least 10 years and be at least biennial. Preventative therapy should be considered given the high BC SIR and ER positivity of subsequent tumours.
Authors
- Ashu Gandhi (ORCID: https://orcid.org/0000-0002-7264-6201)
- Sacha J. Howell (ORCID: https://orcid.org/0000-0001-8141-6515)
- Elaine F. Harkness (ORCID: https://orcid.org/0000-0001-6625-7739)
- Anthony Howell (ORCID: https://orcid.org/0000-0002-6233-719X)
- Susan Pritchard (ORCID: https://orcid.org/0000-0001-6209-6050)
- Nicole Brown
- D. Gareth Evans (ORCID: https://orcid.org/0000-0002-8482-5784)
- Yit Yoong Lim
Institutions
- University of Manchester (GB)
- Manchester University NHS Foundation Trust (GB)
- Cancer Research UK Manchester Institute (GB)
- Wythenshawe Hospital (GB)
Publication Details
- Journal
- BJC Reports
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1038/s44276-024-00113-2
- Citations
- 1
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Institute for Health and Care Research
- Manchester Biomedical Research Centre